• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Impella Shows Lower 30-Day Mortality but Higher Bleeding Risks Than IABP

by
November 17, 2026
in Health
Reading Time: 3 mins read
0
Impella Shows Lower 30-Day Mortality but Higher Bleeding Risks Than IABP

Impella Shows Lower 30-Day Mortality but Higher Bleeding Risks Than IABP

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A meta-analysis comparing left ventricular unloading devices during veno-arterial extracorporeal membrane oxygenation found that Impella was linked to lower 30-day mortality but higher rates of central nervous system and access-site bleeding compared to an intra-aortic balloon pump.

Veno-arterial extracorporeal membrane oxygenation is used for refractory cardiogenic shock, but retrograde aortic flow increases left ventricular afterload, impairing myocardial recovery. Adjunctive unloading strategies, including the intra-aortic balloon pump and Impella, are commonly employed to alleviate this burden, though comparative clinical outcomes have remained unclear.

To evaluate comparative efficacy, researchers performed a systematic review and meta-analysis of studies comparing Impella against intra-aortic balloon pumps for left ventricular unloading during veno-arterial extracorporeal membrane oxygenation in adults. Medical databases were searched through January 15, 2026. Clinically significant bleeding served as the primary outcome, while secondary endpoints included central nervous system hemorrhage, access-site bleeding, gastrointestinal bleeding, renal replacement therapy, in-hospital mortality, and 30-day mortality. Random-effects models were utilized to calculate pooled risk ratios and 95 percent confidence intervals.

Seven retrospective studies encompassing 592 adult patients were included, with 250 receiving Impella and 342 receiving an intra-aortic balloon pump. Six studies contributed data to the primary bleeding analysis, covering 221 Impella patients and 314 balloon pump recipients. Clinically significant or author-reported bleeding occurred in 58.8 percent of Impella-treated patients compared with 37.6 percent of balloon pump patients. This yielded a pooled risk ratio of 1.44 with a 95 percent confidence interval of 0.93 to 2.24 and an I-squared heterogeneity of 90 percent, indicating no statistically significant difference in primary bleeding.

Analysis of specific bleeding complications demonstrated significant differences between the two mechanical devices. Impella use was associated with an increased incidence of central nervous system hemorrhage, showing a pooled risk ratio of 3.64 with a 95 percent confidence interval of 1.32 to 10.07. Access-site bleeding was also significantly higher in Impella cohorts, yielding a risk ratio of 1.94 with a 95 percent confidence interval of 1.11 to 3.41. In contrast, gastrointestinal bleeding did not differ significantly between cohorts, exhibiting a pooled risk ratio of 1.58 with a 95 percent confidence interval of 0.65 to 3.84.

Secondary non-bleeding complications and mortality metrics revealed distinct patterns across the studied populations. The need for renal replacement therapy did not differ significantly, showing a pooled risk ratio of 1.27 with a 95 percent confidence interval of 0.89 to 1.80. In-hospital mortality was similarly comparable between groups, with a risk ratio of 0.98 and a 95 percent confidence interval of 0.71 to 1.37. However, pooled 30-day mortality was significantly lower in the Impella cohorts, presenting a pooled risk ratio of 0.79 with a 95 percent confidence interval of 0.64 to 0.99.

The authors noted that available evidence indicates Impella is associated with higher rates of selected bleeding complications, particularly central nervous system and access-site hemorrhage, alongside a favorable 30-day mortality rate. Because all included investigations were retrospective with nonrandomized treatment allocation, the authors cautioned that these findings should be interpreted as hypothesis-generating rather than establishing causal relationships. Consequently, prospective clinical trials with standardized bleeding and anticoagulation reporting remain necessary to define the optimal left ventricular unloading strategy during veno-arterial extracorporeal membrane oxygenation.

Subject of Research: Comparative bleeding and mortality outcomes of Impella versus IABP for left ventricular unloading during VA-ECMO

Article Title: Bleeding and survival outcomes with Impella versus IABP for left ventricular unloading during VA-ECMO: a systematic review and meta-analysis

Article References: Bartlett, A., Gachineiro, A., & Smith, C. (2026). Bleeding and survival outcomes with Impella versus IABP for left ventricular unloading during VA-ECMO: a systematic review and meta-analysis. Journal of Cardiothoracic Surgery. https://doi.org/10.1186/s13019-026-04798-z

Image Credits: AI Generated

DOI: 10.1186/s13019-026-04798-z

Keywords: veno-arterial extracorporeal membrane oxygenation, VA-ECMO, Impella, intra-aortic balloon pump, IABP, left ventricular unloading, cardiogenic shock, central nervous system hemorrhage, access-site bleeding, gastrointestinal bleeding, renal replacement therapy, in-hospital mortality, 30-day mortality, systematic review, meta-analysis, retrograde aortic flow, myocardial recovery, anticoagulation reporting

News Source: Ophelia Keating. (November 17, 2026). Impella Shows Lower 30-Day Mortality but Higher Bleeding Risks Than IABP. Scienmag.

Tags: 30-day mortalityaccess-site bleedinganticoagulation reportingcardiogenic shockcentral nervous system hemorrhagegastrointestinal bleedingIABPImpellaIn-hospital mortalityintra-aortic balloon pumpleft ventricular unloadingMeta-analysismyocardial recoveryrenal replacement therapyretrograde aortic flowsystematic reviewVA ECMOveno-arterial extracorporeal membrane oxygenation
Share12Tweet7Share2ShareShareShare1

Related Posts

Video-EEG with Polygraphy Identifies Cyanotic Breath-Holding Spell in Infant Case

Video-EEG with Polygraphy Identifies Cyanotic Breath-Holding Spell in Infant Case

November 17, 2026
Longitudinal Studies Reveal Early Executive Function Divergence Across Intellectual and Developmental Disabilities

Longitudinal Studies Reveal Early Executive Function Divergence Across Intellectual and Developmental Disabilities

November 17, 2026

Optimizing Antiemetic Therapy to Improve Supportive Care in Cancer Patients

November 17, 2026

Education and Regional Targeting Drive Optimal Antenatal Care Completion in Uganda

November 17, 2026

POPULAR NEWS

  • Sesbania Hay Replacement Modifies Lamb Muscle Lipids and Meat Flavor Precursors

    Sesbania Hay Replacement Modifies Lamb Muscle Lipids and Meat Flavor Precursors

    29 shares
    Share 12 Tweet 7
  • Human Guided Knowledge Fusion Enhances Industrial Fault Diagnosis Graphs and Retrieval

    29 shares
    Share 12 Tweet 7
  • Geostatistical Kriging Maps Regional Ionospheric Storm Anomalies Across Türkiye

    29 shares
    Share 12 Tweet 7
  • Pediatric Mononucleosis Study Finds Exploratory Links Between Viral Load and Laboratory Measures

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Video-EEG with Polygraphy Identifies Cyanotic Breath-Holding Spell in Infant Case

Longitudinal Studies Reveal Early Executive Function Divergence Across Intellectual and Developmental Disabilities

Optimizing Antiemetic Therapy to Improve Supportive Care in Cancer Patients

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.